Clinical Commissioning Policy: 18Ffluorodeoxyglucose (FDG) positron emission tomography-computedtomography (PET CT) as part of radical radiotherapy treatment planning for oesophageal cancer (all ages) – NHS England

NHS England will not routinely commission 18F-FDG-PET CT as part of radical radiotherapy treatment planning for oesophageal cancer in accordance with the criteria outlined in this document. In creating this policy NHS England has reviewed this clinical condition and the

National Oesophago-Gastric Cancer Audit Report 2017 – Healthcare Quality Improvement Partnership

This 2017 Annual Report from the National Oesophago-Gastric Cancer Audit provides the most up-to-date information on the care and outcomes of patients diagnosed with OG cancer or oesophageal high grade dysplasia.